001     136849
005     20240229105103.0
024 7 _ |a 10.1038/s41591-018-0095-6
|2 doi
024 7 _ |a pmid:29988124
|2 pmid
024 7 _ |a 1078-8956
|2 ISSN
024 7 _ |a 1546-170X
|2 ISSN
024 7 _ |a altmetric:44730680
|2 altmetric
037 _ _ |a DKFZ-2018-01287
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Bunse, Lukas
|0 P:(DE-He78)e579130c57e8c686ed1c2dedfa595985
|b 0
|e First author
245 _ _ |a Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.
260 _ _ |a New York, NY
|c 2018
|b Nature America Inc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1659534345_29254
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The oncometabolite (R)-2-hydroxyglutarate (R-2-HG) produced by isocitrate dehydrogenase (IDH) mutations promotes gliomagenesis via DNA and histone methylation. Here, we identify an additional activity of R-2-HG: tumor cell-derived R-2-HG is taken up by T cells where it induces a perturbation of nuclear factor of activated T cells transcriptional activity and polyamine biosynthesis, resulting in suppression of T cell activity. IDH1-mutant gliomas display reduced T cell abundance and altered calcium signaling. Antitumor immunity to experimental syngeneic IDH1-mutant tumors induced by IDH1-specific vaccine or checkpoint inhibition is improved by inhibition of the neomorphic enzymatic function of mutant IDH1. These data attribute a novel, non-tumor cell-autonomous role to an oncometabolite in shaping the tumor immune microenvironment.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Pusch, Stefan
|0 P:(DE-He78)f2efee17b6ca2f790176a2c036912536
|b 1
|e First author
700 1 _ |a Bunse, Theresa
|0 P:(DE-He78)e681100c540b628a2bdbd48772b4fb50
|b 2
|e First author
700 1 _ |a Sahm, Felix
|0 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
|b 3
700 1 _ |a Sanghvi, Khwab
|0 P:(DE-He78)ca9f3aa4fcee93af10f7e792516e7193
|b 4
700 1 _ |a Friedrich, Mirco
|0 P:(DE-He78)1cab354af0aff62f1b8d569477b4be4c
|b 5
700 1 _ |a Alansary, Dalia
|b 6
700 1 _ |a Sonner, Jana
|0 P:(DE-He78)1f1efec9a95d1778031cb6f0b19ba58b
|b 7
700 1 _ |a Green, Edward
|0 P:(DE-He78)9b97ca569bcb00dfda69382bc7261700
|b 8
700 1 _ |a Deumelandt, Katrin
|0 P:(DE-He78)c1a5de00fb2617c5c43d8f30f6e0cd2b
|b 9
700 1 _ |a Kilian, Michael
|0 P:(DE-He78)bed62b0b74cf1048663fbefeb4b5d7bc
|b 10
700 1 _ |a Neftel, Cyril
|b 11
700 1 _ |a Uhlig, Stefanie
|b 12
700 1 _ |a Kessler, Tobias
|0 P:(DE-He78)5c2c9cbe6ce72553684d82d94aebdadd
|b 13
700 1 _ |a von Landenberg, Anna
|0 P:(DE-He78)e33cce63a8732306894f1135dca8e119
|b 14
700 1 _ |a Berghoff, Anna Sophie
|0 P:(DE-He78)5b87d282e810365cc9599b1384318145
|b 15
700 1 _ |a Marsh, Kelly
|b 16
700 1 _ |a Steadman, Mya
|b 17
700 1 _ |a Zhu, Dongwei
|b 18
700 1 _ |a Nicolay, Brandon
|b 19
700 1 _ |a Wiestler, Benedikt
|b 20
700 1 _ |a Breckwoldt, Michael
|0 P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303
|b 21
700 1 _ |a Al-Ali, Ruslan
|b 22
700 1 _ |a Karcher-Bausch, Simone
|0 P:(DE-He78)c9818cef5adc6714cbfeaabbb69d582b
|b 23
700 1 _ |a Bozza, Matthias
|0 P:(DE-He78)3391c5ad790ea5359189d11f073fb103
|b 24
700 1 _ |a Oezen, Iris
|0 P:(DE-He78)19ad2213f94e3900fa9a1b02f36b965a
|b 25
700 1 _ |a Kramer, Magdalena
|0 P:(DE-He78)4264d8c0f0ad49ff43e0c97a1224d02b
|b 26
700 1 _ |a Meyer, Jochen
|0 P:(DE-He78)b6273c0ba3ae37a4d3d1c6b084797f2e
|b 27
700 1 _ |a Habel, Antje
|0 P:(DE-He78)e1415e1a2d46648d49fa06d0c58b90df
|b 28
700 1 _ |a Eisel, Jessica
|0 P:(DE-He78)e64e97dc855086214ab44e4290f396cd
|b 29
700 1 _ |a Poschet, Gernot
|b 30
700 1 _ |a Weller, Michael
|b 31
700 1 _ |a Preusser, Matthias
|b 32
700 1 _ |a Nadji-Ohl, Minou
|b 33
700 1 _ |a Thon, Niklas
|b 34
700 1 _ |a Burger, Michael C
|0 P:(DE-HGF)0
|b 35
700 1 _ |a Harter, Patrick
|0 P:(DE-He78)b15b56a6ed37417d476470c60c0140ff
|b 36
700 1 _ |a Ratliff, Miriam
|0 P:(DE-HGF)0
|b 37
700 1 _ |a Harbottle, Richard
|0 P:(DE-He78)15dff5647002b4dcfe892b251cd14b62
|b 38
700 1 _ |a Benner, Axel
|0 P:(DE-He78)e15dfa1260625c69d6690a197392a994
|b 39
700 1 _ |a Schrimpf, Daniel
|0 P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc
|b 40
700 1 _ |a Okun, Jürgen
|b 41
700 1 _ |a Herold-Mende, Christel
|b 42
700 1 _ |a Turcan, Sevin
|b 43
700 1 _ |a Kaulfuss, Stefan
|b 44
700 1 _ |a Hess-Stumpp, Holger
|b 45
700 1 _ |a Bieback, Karen
|b 46
700 1 _ |a Cahill, Daniel P
|b 47
700 1 _ |a Plate, Karl H
|0 P:(DE-HGF)0
|b 48
700 1 _ |a Hänggi, Daniel
|b 49
700 1 _ |a Dorsch, Marion
|b 50
700 1 _ |a Suvà, Mario L
|0 0000-0001-9898-5351
|b 51
700 1 _ |a Niemeyer, Barbara A
|b 52
700 1 _ |a von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 53
700 1 _ |a Wick, Wolfgang
|0 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee
|b 54
700 1 _ |a Platten, Michael
|0 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5
|b 55
|e Last author
773 _ _ |a 10.1038/s41591-018-0095-6
|g Vol. 24, no. 8, p. 1192 - 1203
|0 PERI:(DE-600)1484517-9
|n 8
|p 1192 - 1203
|t Nature medicine
|v 24
|y 2018
|x 1546-170X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:136849
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)e579130c57e8c686ed1c2dedfa595985
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)f2efee17b6ca2f790176a2c036912536
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)e681100c540b628a2bdbd48772b4fb50
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)ca9f3aa4fcee93af10f7e792516e7193
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)1cab354af0aff62f1b8d569477b4be4c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)1f1efec9a95d1778031cb6f0b19ba58b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)9b97ca569bcb00dfda69382bc7261700
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)c1a5de00fb2617c5c43d8f30f6e0cd2b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)bed62b0b74cf1048663fbefeb4b5d7bc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)5c2c9cbe6ce72553684d82d94aebdadd
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)e33cce63a8732306894f1135dca8e119
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)5b87d282e810365cc9599b1384318145
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)c9818cef5adc6714cbfeaabbb69d582b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)3391c5ad790ea5359189d11f073fb103
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)19ad2213f94e3900fa9a1b02f36b965a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)4264d8c0f0ad49ff43e0c97a1224d02b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)b6273c0ba3ae37a4d3d1c6b084797f2e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)e1415e1a2d46648d49fa06d0c58b90df
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)e64e97dc855086214ab44e4290f396cd
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-He78)b15b56a6ed37417d476470c60c0140ff
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)15dff5647002b4dcfe892b251cd14b62
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 39
|6 P:(DE-He78)e15dfa1260625c69d6690a197392a994
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 40
|6 P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 48
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 53
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 54
|6 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 55
|6 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Translational cancer research
|x 0
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT MED : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT MED : 2015
920 1 _ |0 I:(DE-He78)G160-20160331
|k G160
|l Neuroimmunologie und Hirntumorimmunologie
|x 0
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 1
920 1 _ |0 I:(DE-He78)G380-20160331
|k G380
|l KKE Neuropathologie
|x 2
920 1 _ |0 I:(DE-He78)F160-20160331
|k F160
|l F160 DNA-Vektoren
|x 3
920 1 _ |0 I:(DE-He78)L501-20160331
|k L501
|l DKTK Frankfurt
|x 4
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G160-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a I:(DE-He78)G380-20160331
980 _ _ |a I:(DE-He78)F160-20160331
980 _ _ |a I:(DE-He78)L501-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21